Literature DB >> 11764073

Portal tract eosinophils and hepatocyte cytokeratin 7 immunoreactivity helps distinguish early-stage, mildly active primary biliary cirrhosis and autoimmune hepatitis.

N S Goldstein1, A Soman, S C Gordon.   

Abstract

We studied nondiagnostic liver biopsy specimens from 20 patients with definite primary biliary cirrhosis (PBC) and 18 with definite autoimmune hepatitis (AIH) to identify distinguishing features. All patients had early-stage disease; biopsy specimens were devoid of granulomas or diagnostic features of PBC or AIH. Diagnoses were based on serologic and clinical variables. Sixteen specimens from each group were immunostained with cytokeratin 7. The density of portal tract eosinophils and number with cytokeratin 7-reactive periportal hepatocytes were quantified. Sixteen of 18 patients with AIH and 13 of 20 with PBC had no or minimal bile duct injury. Histologic activity index scores were 5.8 in AIH and 5.7 in PBC. The mean portal eosinophil score was greater in PBC than in AIH. Cytokeratin 7 identified many central bile ducts that were obscured by portal inflammation. The mean periportal cytokeratin 7-reactive hepatocyte score was greater in PBC than in AIH. Portal eosinophils and cytokeratin 7 reactivity in periportal hepatocytes are supportive of PBC rather than AIH. No morphologic features were supportive of AIH. Cytokeratin 7 reactivity in periportal hepatocytes may be an early response to PBC-induced biliary obstruction in other regions of the liver.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11764073     DOI: 10.1309/VHHD-HTRU-N8J2-5X7R

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

1.  Cutaneous lesions as presenting symptoms of primary biliary cirrhosis: an undifferentiated connective tissue disease-like onset.

Authors:  Michele Covelli; Ivana Favia; Mariapia Marrone; Florenzo Iannone; Antonia Gentile; Gaetano Lastilla; Giovanni Lapadula
Journal:  Clin Rheumatol       Date:  2005-11-03       Impact factor: 2.980

2.  Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria.

Authors:  Dana Balitzer; Nafis Shafizadeh; Marion G Peters; Linda D Ferrell; Najeeb Alshak; Sanjay Kakar
Journal:  Mod Pathol       Date:  2017-01-20       Impact factor: 7.842

Review 3.  Overlap syndromes of autoimmune hepatitis: what is known so far.

Authors:  Marilena Durazzo; Alberto Premoli; Sharmila Fagoonee; Rinaldo Pellicano
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

4.  NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis.

Authors:  Junichiro Irie; Yuehong Wu; Linda S Wicker; Daniel Rainbow; Michael A Nalesnik; Raphael Hirsch; Laurence B Peterson; Patrick S C Leung; Chunmei Cheng; Ian R Mackay; M Eric Gershwin; William M Ridgway
Journal:  J Exp Med       Date:  2006-04-24       Impact factor: 14.307

Review 5.  Overlap syndromes: an emerging diagnostic and therapeutic challenge.

Authors:  Pooja Dhiman; Sharad Malhotra
Journal:  Saudi J Gastroenterol       Date:  2014 Nov-Dec       Impact factor: 2.485

6.  Keratin 7 expression in hepatic cholestatic diseases.

Authors:  S Sakellariou; C Michaelides; T Voulgaris; J Vlachogiannakos; E Manesis; D G Tiniakos; I Delladetsima
Journal:  Virchows Arch       Date:  2021-07-27       Impact factor: 4.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.